Rutger M. Van Den Bor

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Haemorrhagic Safety Update of CLEAR-PATH: 30 Day and 12 Month Antiplatelet Therapy After Peripheral Angioplasty.

Haemorrhagic Safety Update of CLEAR-PATH: 30 Day and 12 Month Antiplatelet Therapy After Peripheral Angioplasty.

Journal: EJVES vascular forum

Published: May 11, 2025

Mental Health Changes in Adolescents and Adults With Cystic Fibrosis After Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Insights From the Longitudinal Resilience Impacted by Positive Stressful Events (RISE) Study.

Mental Health Changes in Adolescents and Adults With Cystic Fibrosis After Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Insights From the Longitudinal Resilience Impacted by Positive Stressful Events (RISE) Study.

Journal: CHEST pulmonary

Published: February 07, 2025

Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis.

Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic Fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 25, 2024

Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH).

Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH).

Journal: American heart journal

Published: October 24, 2023

Cohort data with dropout: a simulation study comparing five longitudinal analysis methods.

Cohort data with dropout: a simulation study comparing five longitudinal analysis methods.

Journal: BMC medical research methodology

Published: August 26, 2023

The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis.

The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosis.

Journal: ERJ open research

Published: October 12, 2022

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators.

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators.

Journal: Journal of personalized medicine

Published: November 23, 2021

Estimation and expected sample size in Simon's two-stage designs that stop as early as possible.

Estimation and expected sample size in Simon's two-stage designs that stop as early as possible.

Journal: Pharmaceutical statistics

Published: May 07, 2021

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Journal: BMJ open

Published: January 01, 2020

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.

Journal: Circulation

Published: December 28, 2018

Predicting enrollment performance of investigational centers in phase III multi-center clinical trials.

Predicting enrollment performance of investigational centers in phase III multi-center clinical trials.

Journal: Contemporary clinical trials communications

Published: February 08, 2017

Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.

Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.

Journal: Journal of clinical epidemiology

Published: September 27, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026